Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm

By News Health
14 hours Ago

(MedPage Today) — SAN FRANCISCO — Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease control with a novel KRAS G12D inhibitor, a small preliminary study showed.
The early results showed that…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119372

Author :

Publish date : 2026-01-10 14:01:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

What Do the New Dietary Guidelines Emphasize?

Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

Global Pain Levels; Tertiary Patents on FDA-Approved Drugs

The True Miracle of Ivermectin

'The Pitt' Is Back for Another Harrowing 15-Hour Shift

What's the Best Diet for a Longer, Healthier Life?